Qingdao · Remote ok
Agilent Technologies
About Agilent Technologies
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio.
Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories.
Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life.
In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.
Open positions · 100
Hyderabad · On-site
Boston · Remote ok · $94k–$176k/yr
Goiânia · On-site
Saint-Laurent-du-Maroni · Hybrid · $42k–$65k/yr
Manesar · On-site
Illinois · Remote ok · $122k–$191k/yr
Beijing · On-site
Carpinteria · Remote ok · $105k–$197k/yr
Manesar · On-site
Frederick · On-site · $31/hr–$49/hr
Manesar · On-site
New Delhi · Remote ok
Manesar · On-site
Frederick · On-site · $31/hr–$49/hr
George Town · Hybrid
Windsor · On-site · $24/hr–$42/hr
Folsom · On-site · $28/hr–$44/hr
Windsor · On-site · $83k–$130k/yr
Barcelona · On-site
Angical · Hybrid
Barcelona · On-site
Barcelona · On-site
Windsor · On-site · $83k–$130k/yr
Manesar · Remote ok
Windsor · On-site · $17/hr–$29/hr
Mumbai City · On-site
Washington · Remote ok · $133k–$250k/yr
Beijing · Remote ok
Windsor · On-site · $20/hr–$35/hr
Windsor · On-site · $17/hr–$29/hr
Dover · Remote ok · $19/hr–$24/hr
Windsor · On-site · $108k–$168k/yr
Santa Clara · On-site · $144k–$270k/yr
Memphis · On-site · $20/hr–$32/hr
Barcelona · On-site · $196k–$307k/yr
Glostrup · On-site
Windsor · On-site · $89k–$138k/yr
Barcelona · On-site
Santa Clara · Remote ok · $211k–$329k/yr
Manesar · On-site
Shanghai · On-site
Hyderabad · On-site
Manesar · On-site
Brazil · Hybrid
Los Angeles · Remote ok · $50/hr–$101/hr
Washington · Remote ok · $124k–$233k/yr
Santa Clara · On-site · $180k–$281k/yr
Ciudad de México · Remote ok
Folsom · On-site · $115k–$180k/yr
Santa Clara · On-site · $217k–$340k/yr
Singapore · On-site
Maryland · Remote ok · $34/hr–$53/hr
Barcelona · Remote ok
Wilmington · Hybrid · $22/hr–$35/hr
Middelburg · On-site
Charlottetown · On-site · $17/hr–$29/hr
Barcelona · Remote ok · $144k–$270k/yr
Folsom · On-site · $28/hr–$44/hr
Beijing · On-site
Japan · Remote ok
Barcelona · On-site
Guangzhou City · Remote ok
Beijing · Remote ok
Carpinteria · On-site · $110k–$173k/yr
Barcelona · Remote ok
Brazil · Hybrid
Wilmington · On-site · $22/hr–$35/hr
Glostrup · Remote ok
Chengdu · Remote ok
Waldbronn · On-site
Japan · Remote ok
Santa Clara · Remote ok · $136k–$255k/yr
Cedar Creek · On-site · $66k–$104k/yr
Charlottetown · On-site · $24/hr–$42/hr
Beijing · On-site
Waldbronn · On-site
Wilmington · Remote ok · $136k–$255k/yr
Manesar · On-site
Japan · Remote ok
Winooski · On-site · $30/hr–$47/hr
Glostrup · On-site
Brazil · On-site
Barcelona · On-site
Santa Clara · Hybrid · $173k–$270k/yr
Santa Clara · On-site · $55/hr–$86/hr
Seoul · On-site
Seoul · Remote ok
Barcelona · On-site
Baton Rouge · Remote ok · $34/hr–$53/hr
Wilmington · On-site · $136k–$212k/yr
Church Stretton · On-site
George Town · On-site
Barcelona · On-site
Barcelona · On-site
Shanghai · On-site
Japan · Remote ok
Shanghai · On-site
Shanghai · On-site
Shanghai · On-site
Company at a glance
Where Agilent Technologies is hiring
Frequently asked questions
Companies similar to Agilent Technologies
EVANIUM is a Regensburg, Germany–based life-science startup that aims to unleash the potential of plant compounds. The company uses its OPTISOLV platform to transform plant extracts into highly water-soluble, stable ingredients, serving customers in Germany and the USA and drawing international interest from Korea and beyond. With a 12-person team, EVANIUM has raised 2.2 million euros in seed funding led by Foodlabs and Phis, with investors including Böhringer Ingelheim and Razorfarm, and has earned an award at Vitafood. This year the company reported 350,000 euros in revenue and produced 2.5 tons of raw material, positioning itself as an innovative player in the plant-based ingredient market.
9 Mothers Defense develops fast and cost-effective counter-small UAS (C-sUAS). The company uses AI for detection, tracking and defensive systems to protect against aerial threats, building AI-powered machines designed to intercept and neutralize Group 1/sUAS threats in real time. Operating in the defense industry with a focus on immediate threat countermeasures, it pursues mission-critical work countering immediate real-world aerial threats. Meaningful early equity for foundational owners and direct roadmap influence give employees a seat at the table shaping product and technology trajectory from day one, with zero red tape allowing them to make technical decisions autonomously. An on-site team in Austin, Texas builds robots, sensors and models to control them from scratch, using Python and Rust on embedded hardware, and their work spans vision, acoustics, radar and control systems across hardware and software.
Aira is an AI platform designed for procedural specialties that serves as the payer intelligence layer for medical device companies and surgical practices. The company automates critical back-office workflows while handling the full payer compliance lifecycle, including benefits verification, medical necessity determinations, prior authorization, and appeals management. By functioning as the intelligence layer powering market access teams, Aira helps healthcare providers and device manufacturers navigate the complexity of reimbursement processes to increase patient access to needed procedures. The platform addresses a key pain point in healthcare operations by streamlining the administrative burden that often delays care and complicates market entry for medical innovations.